Top Industry Leaders in the Leprosy Treatment Market
GlaxoSmithKline (GSK) longstanding anti-leprosy drug clofazimine remains a key component of MDT regimens and GSK actively participates in global leprosy control initiatives.
Novartis Continues to provide their anti-leprosy drug rifampicin through various programs and partnerships, contributing to treatment access in affected regions.
Bayer Collaborates with the World Health Organization and other partners on leprosy research and development initiatives, including exploring new drug combinations and diagnostics.
Sandoz (Novartis) Offers generic versions of essential anti-leprosy drugs like clofazimine and dapsone, contributing to affordability and wider access to treatment in resource-limited settings.
Institute for One World Health (IOWH) Develops and advocates for affordable, readily available, and user-friendly treatment options like fixed-dose combinations for leprosy, simplifying administration and potentially improving adherence.
List of Leprosy treatment Key Companies in the Market
- Glaxo Smithcline
- Systopic Laboratories Pvt. Ltd.
- Cadila Pharmaceuticals
- Acme Pharmaceuticals
- Macleods Pharmaceuticals
- Novartis International AG
- Astra Zeneca
- Lark Laboratories Ltd